Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension. J Clin Endocrinol Metab 1977;44:924-33. 4 Case report A girl, aged 2-years at the time of this report, had been observed since birth. Her mother was known to have a sporadic form of HR with severe bone abnormalities (osteomalacia) and dwarfism, and had been treated during infancy with combined phosphates and vitamin D3 without any improvement. The pregnancy was normal, and a caesarean section was performed for maternal indications.
1la,25-dihydroxycholecalciferol and phosphate. She has not, so far, developed osseous lesions.
Recent research into the metabolism of vitamin D has led to knowledge of its active forms and treatment applications. Despite its successful therapeutic effects in hypophosphataemic rickets (HR), opening a new field in the physiopathological research into this disease, not all the mechanisms are known. We present a patient in whom the early treatment of familial HR with I a,25-dihydroxycholecalciferol (1 c,25(OH2)3) and phosphate (Joulie's solution) prevented the onset of bone lesions.
Case report A girl, aged 2-years at the time of this report, had been observed since birth. Her mother was known to have a sporadic form of HR with severe bone abnormalities (osteomalacia) and dwarfism, and had been treated during infancy with combined phosphates and vitamin D3 without any improvement. The pregnancy was normal, and a caesarean section was performed for maternal indications. Our patient's birthweight was 3-3 kg and her length was 52 cm.
A physical examination at age 2 months showed her to be normal-weight and height at the 25th centile. Laboratory investigations at that time found the following: hypophosphataemia-phosphate 1 13 mmol/l (3 5 mg/dl), normal range for our laboratory I 29-2-09 mmol/l; normal serum calcium 2-23 mmol/l (9-2 mg/dl), normal range 2-1-2-6 mmol/l; raised alkaline phosphatase-56 KA units, normal range 7-5-32*5 KA units; hypocalciuria-0 0365 mmol/kg/24 hours (1 46 mg/kg/24 hours); hyperphosphaturia-45-54 mmol/l 73m2/24 hours (1 41 mg/ 173m2/24 hours); and a reduction in renal tubular reabsorption of phosphate-60 %.
Renal function parameters were normal: glomerular filtration rate (GFR) estimated by creatinine clearance was 70 ml/1 * 73 m2/minute, with GFR of sodium, calcium, and potassium 0 09 ml/100 ml, 0-17 ml/100 ml, and 6-98 ml/100 ml of filtrate. Aminoaciduria was normal, urine density was 1028; and pH 5. Plasma bicarbonate was 23 -8 (mEq) mmol/l and plasma pH was 7-38. After intravenous loading of phosphate there was an important reduction in the maximal tubularexcretory capacity of phosphate (GFR 3-6 mg (1-2 mmol)/ 100 ml filtrate). Knee and wrist radiographs were normal. Treatment with oral phosphate was started at an dosage of 600 mg/day (in 6 divided doses) and ,25(0H2)5 at a dosage of 0-25 ,tg/day. These doses were increased until the alkaline phosphatase value was normal-at 2-2 g/day phosphate and 1-25 ,ug/day la,25(OH2)3. Plasma phosphate was always above 1 066 mml/l (3 ,tg/dl) and no hypercalcaemic episodes were detected (Figure) . At the age of 21 years bone radiographs remained normal. Weight and height were at the 75th and 90th centiles respectively, and the maximal tubular excretory capacity of phosphate had dropped to GFR 1 6 mg (0.53 mmol)/100 ml filtrate.
Discussion
With the introduction of the active forms of vitamin D in the treatment of familial HR the outlook for these patients has improved substantially. In our patient the treatment recommended by Moncrieff has prevented bone lesions. When we first saw this girl in 1979 we were concerned about the precise time to begin treatment and considered that the raised alkaline phosphatase value and hypophosphataemia were parameters valid enough to start active treatment for rickets. There have been no important problems associated with treatment and although we have no bone histology, we believe that in the long term and on the basis of the radiographic evidence our patient's bone structure may be normal.
SUMMARY We describe two patients with haemangioma with thrombocytopenia (Kasabach-Merritt syndrome). Both were treated with corticosteroids without notable improvement. The first patient responded satisfactorily to radiotherapy, whereas the second showed a slow spontaneous resolution.
Kasabach and Merritt' first described the syndrome of thrombocytopenia with haemangioma. Approximately 100 cases have been reported subsequently. The haemangioma enlarges, usually in infancy, and at the same time there is a fall in the platelet count, together with hypofibrinogenaemia and a consumption coagulopathy. Radioisotope studies have shown an increased uptake within the haemangioma of platelets or fibrinogen, or of both.2 Surgery is not always possible. Radiotherapy, corticosteroids, anticoagulants, and antifibrinolytics have all been used, but none is clearly superior. We report two girls with haemangioma and thrombocytopenia in whom the use of corticosteroids was of little or no benefit.
Case reports Case 1. The haemangioma presented at the age of 51 weeks, and progressively enlarged. On admission at 7 weeks there was an extensive firm swelling below the chin extending into the neck on both sides but more on the right where it extended to the angle of the jaw (Figure) . The haemangioma was also visible on the floor of the mouth below the tongue. The liver was palpable 3 cm below the costal margin. Investigations showed haemoglobin 8 5 g/dl, white cells 7 9 x1O9/l, and platelets 20 x109/l. The blood film showed microcytosis, anisocytosis, burr cells, and a normal differential. The prothrombin time was 12-5 seconds (control 11-5 seconds), activated partial thromboplastin time 45 seconds (control 43 seconds), and fibrin degradation products between 10 and 40 ,ug/ml (normal less than 10 ,ug/ml).
Treatment with epsilon aminocaproic acid and vitamin K was given for three weeks, followed by one week of prednisolone 4 mg/kg/day, but the haemangioma continued to enlarge rapidly and the platelet count fell to 9 x 109/l. Surgical removal was impossible. Diminution in the size of the lesion occurred after a single dose of radiation (400 rads), but this was followed by enlargement of the lesion and haematological relapse. A second dose of 400 rads was followed by slow and complete regression of the lesion, so that the lesion had entirely disappeared by 14 months of age.
Case 2. A red swelling on the medial side of the left knee, presented at the age of 3 months, diagnosed initially as cellulitis and treated with penicillin.
